Tissue DistributionPaclitaxelAntineoplastic Agents, PhytogenicAntineoplastic Combined Chemotherapy ProtocolsCarboplatinDrug Administration ScheduleOvarian NeoplasmsTubulin ModulatorsDrug Resistance, NeoplasmCisplatinInfusions, IntravenousTaxoidsLung NeoplasmsBreast NeoplasmsAntineoplastic AgentsDoxorubicinTreatment OutcomeBridged CompoundsDose-Response Relationship, DrugCarcinoma, Non-Small-Cell LungNeutropeniaTaxusCell Line, TumorTubulinEpothilonesPharmaceutical VehiclesDeoxycytidineDrug SynergismDisease-Free SurvivalMaximum Tolerated DoseArea Under CurveP-GlycoproteinPeripheral Nervous System DiseasesEpirubicinSurvival AnalysisMice, NudeFallopian Tube NeoplasmsMicrotubulesTopotecanVinblastineCombined Modality TherapyNeoplasmsTumor Cells, CulturedApoptosisSurvival RateXenograft Model Antitumor AssaysDrug Resistance, MultipleDrug CarriersNeoplasm StagingDrug Delivery SystemsDrug Screening Assays, AntitumorAntibodies, Monoclonal, HumanizedCyclophosphamidePeritoneal Neoplasms